Ignite Creation Date:
2025-12-25 @ 1:31 AM
Ignite Modification Date:
2026-01-31 @ 1:21 PM
Study NCT ID:
NCT00281294
Status:
TERMINATED
Last Update Posted:
2008-08-05
First Post:
2006-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Study to Evaluate the Safety, Tolerability, and Activity of Fontolizumab in Subjects With Active Rheumatoid Arthritis
Sponsor:
PDL BioPharma, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ZAF-711
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None